featured
Role of Stem Cell Transplant in CD30+ PTCL After Frontline Brentuximab Vedotin+CHP or CHOP
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Role of Stem Cell Transplant in CD30-positive PTCL following Frontline Brentuximab Vedotin+CHP or CHOP in ECHELON-2
Blood Adv 2022 Apr 25;[EPub Ahead of Print], KJ Savage, SM Horwitz, R Advani, JH Christensen, E Domingo-Domenech, G Rossi, F Morschhauser, O Alpdogan, C Suh, K Tobinai, A Shustov, M Trneny, SLS Yuen, PL Zinzani, LH Truemper, TM Illidge, OA O'Connor, B Pro, H Miao, V Bunn, K Fenton, M Fanale, M Puhlmann, SP IyerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.